Back to Rankings

MAZE

Maze TherapeuticsN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
MAZE vs peer average
50/100
MAZE vs. peer average (N/A vs. C)
Grade spread
A 1 · B 2 · C 2 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

BLFS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.34B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBLFSBioLife Solutions
MAZE
Maze Therapeutics
BLFS
BioLife Solutions
Grade
N/A
A
Momentum
11
82
Value
-
49
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Constructive

Grade position vs BLFS

MAZE / BLFS
Grade Position
In line
MAZE vs. peer average (N/A vs. C)
50/100
Momentum
11
BLFS
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MAZE
1
BLFS
BioLife Solutions Inc Common
A
100/100
-
2
IMTX
Immatics NV Common
B
80/100
-
3
SEPN
Septerna Inc Common
N/A
-
-
4
ARDX
Ardelyx Inc Common
C
60/100
-
5
MLTX
MoonLake Immunotherapeutics Class A Common
D
40/100
-
BLFS is the first peer returned for this comparison set.